Efficiency of nicotinamide-based supportive therapy in lymphopenia for patients with ordinary or severe COVID-19: A randomized controlled trial.

Qiang HuQuan-Yu ZhangCheng-Fei PengZhuang MaYa-Ling Han

Published in: Medicine (2022)

Among patients with COVID-19, there was no statistically significant difference in the change of whole blood counts and absolute lymphocyte counts before and after intervention in both groups. Therefore, no new evidence has been found regarding the effect of niacinamide on lymphopenia in COVID-19 patients.

Keyphrases

sars cov
peripheral blood
coronavirus disease
randomized controlled trial
early onset
cell therapy
replacement therapy